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ABSTRACT
THE EFFECT OF SUPPORTIVE EDUCATION, AS A TERTIARY
NURSING INTERVENTION, ON THE QUALITY OF LIFE
OF PATIENTS WITH HEART FAILURE
By
Julie A Switek
Quality o f life in patients with heart failure is poor. The purpose o f this study was
to examine the impact o f a supportive educational nursing intervention on quality o f life.
The quality o f life o f two groups o f patients with heart failure were compared, the control
group that received placebo interventions and the experimental group that received a
supportive educational intervention. The instrument utilized in this study was the Ferrans
and Powers Quality o f Life Index; Cardiac Version III. Betty Neuman’s systems model
was the theoretical framework that guided this research. Independent and paired T-tests
were utilized to analyze the data. Findings included a significant increase in the quality
o f life scores for the supportive educational group occurring at the 6-month time period.
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CHAPTER 1
INTRODUCTION

Heart failure represents a major health problem for the United States. It is the
nation’s most rapidly growing cardiovascular disorder in the United States and is
increasing in incidence, prevalence, and mortality (Funk & Krumholz, 1996). As
mortality decreases from coronary artery disease, and more people are saved from
premature death, the prevalence o f heart failure will continue to increase. According to
the American Heart Association Heart and Stroke 2000 Statistical Update, heart failure
affects an estimated 4.7 million Americans, with 550,000 new cases occurring annually
(American Heart Association, [AHA], 2000). Heart failure is not only a problem in the
United States, but is also prevalent in Canada, western Europe, and Japan. Combined
with the United States, the estimated number o f people with heart failure exceeds ten
million (Funk & Krumholz, 1996).
The economic impact o f heart failure is staggering.

In 1979, there were

approximately 337,000 hospital discharges annually from congestive heart failure.
Currently there are approximately 978,000 heart failure hospital discharges annually. The
cost o f heart failure is approximately $19.4 billion dollars - $14.3 billion due to hospital
nursing home costs, $1.5 billion in physician costs, $1.6 billion in drugs and other
medical durable costs, and $2.0 billion in home health care (AHA, 2000). Not only are

costs associated with heart failure high, so are the mortality rates. From 1979 to 1998,
congestive heart failure deaths increased 135 percent. The 5-year mortality rate for heart
failure is about 50 percent (AHA, 2000). According to the Framingham Study (Ho,
Pinsky, Kannel, & Levy, 1993), these mortality rates are four to eight times those o f the
general population o f the same age. Heart failure is associated with a shorter life
expectancy than that o f many common types o f cancer.
Successful management o f heart failure is important in the long-term outlook o f
healthcare. It weighs heavily on society with its high cost for treatment, high mortality,
marked disability, and subsequent lack o f productivity o f people with the disease.
Development and assessment o f new therapeutic interventions have become a major area
o f research for heart failure in order to keep patients out o f the hospital and to decrease
mortality and morbidity.
Heart failure research has focused on understanding the pathophysiology and risk
factors associated with heart failure, medical management interventions such as diet and
medication use, and surgical management interventions such as transplantation and
ventricular assist devices (Dracup et al., 1994; Rector & Cohn, 1992; Rogers et al., 1994).
Other research studies have centered on issues related to self-care, home care, symptom
management, and interventions to assist in keeping patients out o f the hospital (Fonarow
et al., 1997; Rich et al., 1995; Shah, Der, Ruggerio, Heidenreich, & Massie, 1998;
Stewart et al., 1989).
These rapid advances in the treatment o f heart failure during the 1980s and 1990s
have been accompanied by a growing interest in health-related quality o f life issues.
According to Dracup et al. (1994), the impact o f heart failure on a patient’s life may be

related as much to psychological adaptation to the disease as to impairment in physical
functioning. Data from the Studies o f Left Ventricular Dysfunction indicate that quality
o f life is a significant, independent predictor o f mortality and heart failure related
hospitalizations (Freedland & Carney, 2000).
The Agency for Health Care Policy and Research Clinical Practice Guideline
entitled “Heart Failure: Evaluation and Care o f Patients with Left-Ventricular Systolic
Dysfunction” (1994), recommends that providers assess patients’ health-related quality o f
life including symptoms, physical functioning, and mental health. This information
needs to modify treatment and guide patient and family teaching to facilitate adaptation
to heart failure. Nursing can play a major role in implementing these guidelines and
strategies that help patients to live with heart failure and improve their quality o f life.
Numerous nursing researchers have studied quality o f life issues related to heart
failure (Dracup, Walden, Stevenson, & Brecht, 1992; Grady, 1993; Grady et al., 1995;
Hawthorne & Hixon, 1994; Jaarsma et al., 2000; Martensson, Karlsson, & Fridlund,
1997, 1998; Scott, 2000; Shively, Fox, & Brass-Mynderse, 1996). The majority o f these
studies examined quality o f life measurement instruments and measured quality o f life
related to symptoms and functional status. A few o f these studies implemented strategies
in order to improve quality o f life.
Grady (1993) examined the definition of quality o f life related to patients with
heart failure and found that health, physical function, psychological function, and social
interactions are the four common dimensions that play a role in these patients’
perceptions o f their quality o f life. Dracup et al. (1992) designed a study to measure
quality o f life in patients with advanced heart failure waiting for transplantation.

Martensson et al. (1997, 1998) studied male and female patients with heart failure and
how they conceptualized their life situation Hawthorne and Hixon (1994) examined the
effects o f a nursing model upon reducing readmission rates and improving quality o f
care. Jaarsma et al. (2000) studied the effects o f a supportive education nursing
intervention on self-care abilities, self-care behaviors, and quality o f life o f patients with
advanced heart failure. Scott (2000) studied heart failure patients receiving home
inotropic infusions and how the caregiver and patient were affected. Rich et al. (1995)
conducted a study utilizing an intervention that consisted o f comprehensive education o f
the patient and family, a prescribed diet, social-service consultation, early discharge
planning, review o f medications, and intensive follow-up. These studies indicate that
health care providers have the ability to recognize the variables that influence quality o f
life, identify patients at risk for poor quality o f life, and assist patients to achieve the
highest quality o f life possible within the constraints o f their disease. Any intervention,
no matter how minimal, may have a beneficial effect on patients with heart failure.
Problem Statement
Many o f the quality o f life studies that specifically studied heart failure patients
(Dracup et al., 1992; Grady, 1993; Grady et al., 1994; Hawthorne & Hixon, 1994; Scott,
2000) found that these patients described their quality o f life as poor. According to
Dracup et al. (1992) and Hawthorne and Hixon (1994) interventions to improve quality o f
life need to be targeted toward reducing depression and hostility, increasing daily activity
levels, improving knowledge o f heart failure, and learning self-care skills. Resources are
spent on technological advances with a goal o f prolonging life, decreasing
hospitalizations, along with decreasing morbidity and mortality. All o f these are

important, but resources also need to be spent not only on increasing life span but on
increasing quality o f life, which can be affected by a patient’s condition or treatment, or
both. Research needs to test interventions that focus on increasing quality o f life.
Nursing interventions need to be studied as well as medical interventions.
Informing and educating the heart failure patient about heart failure treatment and
its consequences was associated with improved quality o f life and a higher overall feeling
o f well-being (Jaarsma et al., 2000). According to Jaarsma et al., this was achieved
through increasing self-care abilities and improving self-care behavior by educating the
patient with heart failure. The purpose o f this study was to examine the impact o f a
supportive educational nursing intervention on quality o f life.

CHAPTER 2
CONCEPTUAL FRAMEWORK AND LITERATURE REVIEW

Conceptual Framework
The conceptual framework that guides this research is Betty Neuman’s systems
model. The Neuman systems model is based on two major components - stress and
reaction to stress. The Neuman systems model has four important nursing concepts client/client system, environment, health, and nursing (Neuman & Fawcett, 2002).
Client
According to the Neuman systems model, the client is viewed as an open,
wholistic system, continuously interacting and relating with the environment. The client
is composed o f physiologic, psychological, sociocultural, developmental, and spiritual
variables. These five variables interact and function together in order to protect the client
from internal and external stressors. Stressors are defined as “tension-producing stimuli
with the potential for causing system instability ” (Neuman & Fawcett, 2002, p. 21).
In a healthy person, the five client variables function in harmony and remain
stable in relation to stressors. In an ill person, the five client variables become unstable in
relation to stressors. The patient with heart failure can illustrate how this instability
occurs. Heart failure is a “clinical syndrome or condition characterized by (1) signs and
symptoms o f intravascular and interstitial volume overload, including shortness of breath,
rales, and edema, or (2) manifestations o f inadequate perfusion, such as fatigue or poor
exercise tolerance” (AHCPR Quick Reference Guide for Clinicians, No. 11, p. 1).
Heart failure is a disease state that can prevent the client variables from
maintaining stability. Heart failure symptoms such as dyspnea, edema, fatigue, exercise

intolerance, and sleeplessness are examples o f physiologic variables that could cause
client instability. Fear, anxiety, depression, and memory loss are examples o f
psychological variables that could cause client instability.
The perception o f an illness and how it affects the client’s life is influenced by the
client’s cultural and socioeconomic background, the sociocultural variable. Role loss
within the family may occur with heart failure due to the client’s inability to continue to
work and support the family. Lifestyle changes are very important in decreasing the
symptoms o f heart failure. Other related social issues such as inadequate finances to
purchase medications, lack o f transportation to appointments, or lack o f a safe place to
exercise can also affect the client negatively. Difficulty coping with these issues may
cause instability within the client’s sociocultural variable.
The client’s developmental variable is related to the developmental stage o f the
client, and how the client reacts to change, or how the client may deal with loss o f
independence. Heart failure is a disease that mainly affects the older adult. Because the
disease can be disabling with multiple lifestyle changes, the client may need assistance
with things that they have never needed help with before. The client can lose
independence and can feel like a burden on family and friends, therefore causing
instability within the developmental variable o f the client.
The spiritual variable is the client’s spiritual beliefs and influences. With heart
failure having a high mortality rate, an important spiritual issue may be the heart failure
client’s belief regarding death and dying, and end o f life issues. If the client has a fear of
dying, this could be one way that heart failure can cause instability within the spiritual
variable o f the client.

Environment
The environment is defined as all the internal and external factors or influences
surrounding the client. According to the Neuman systems model, there are two
protective mechanisms that enhance and maintain the integrity o f the client within the
environment: the normal line o f defense and the flexible line o f defense (Neuman &
Fawcett, 2002). The basic structure or client is the central core o f Neuman’s model and
concentric circles called the lines o f defense and lines o f resistance surround it (see
Figure 1). As the client encounters stress over time, a normal range of responses to the
environment develops. These responses represent the normal line o f defense, which is
the client’s current or usual wellness/stability state. The flexible line o f defense protects
the client from immediate or short-term stressors, therefore protecting the normal line o f
defense. The flexible line o f defense prevents stressors from invading the client system.
If the lines of defense are unable to protect the client against a particular stressor, then a
reaction occurs. A reaction then presents with client instability.
The patient with heart failure can encounter instability within all five o f
Neuman’s variables. Instability o f any o f these entire variables can negatively affect the
patient. Heart failure can be a stressor and break down the lines o f defense. If the patient
with heart failure is unable to protect themselves, a reaction can occur. This reaction
could manifest itself as a perceived decrease in quality o f life. Quality o f life can be
defined as “a person’s sense o f well-being that stems from satisfaction or dissatisfaction
with the areas o f life that are important to him/her” (Ferrans & Powers, 1992, p. 29).
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Figure 1, The Neuman Systems Model: Neuman, B & Fawcett, J. (2002). The Neuman Systems Model (4‘*‘ ed ). Upper Saddle
River, NJ: Prentice Hall. Reprinted with permission (see Appendix A).

Health
Health or wellness is defined as the “condition or the degree o f system stability, in
which all parts or subparts (variables) are in balance or harmony with the whole of the
client or client system” (Neuman & Fawcett, 2002, p. 12). Wellness and illness can be
placed on opposite ends o f a continuum, with health being the best possible wellness state
at any given time, the state of optimal well-being. Neuman views health as “a
manifestation o f living energy available to preserve and enhance system integrity” (p.
23). When the client variables become unstable due to a stressor such as heart failure, the
stressor is then able to penetrate the lines o f defense and a reaction occurs. When this
reaction occurs, it is important for the client to return to an optimal wellness level.
Quality o f life is one important aspect o f optimal wellness for the client with heart failure,
particularly with the increasing ability to prolong life due to technological advances.
These technologic advances may negatively affect the client’s quality o f life.
Nursing
The main focus o f nursing is to keep the client system stable. Nursing is the link
between the client, the environment, and health. Nursing actions and/or interventions are
instituted in order to retain, attain, or maintain optimal client health. Primary, secondary,
and tertiary prevention are nursing interventions to assist in achieving optimal health,
according to the Neuman systems model (Neuman & Fawcett, 2002). Interventions are
based on possible or actual degree o f reaction, resources, goals, and anticipated
outcomes. Interventions should be started when a stressor is either suspected or
identified. In order for nurses to stabilize the client and assist in reconstitution, primary,
secondary, and tertiary interventions are required.
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Primary, secondary, and tertiary interventions. Primary prevention is carried out
as a stressor or potential stressor is suspected or identified but a reaction has not yet
occurred. The primary prevention goal would be to retain heart function and strengthen
the flexible line o f defense in order to decrease the risk o f heart failure and enhance heart
function. Since heart failure is an end result o f other diseases such as coronary artery
disease and hypertension, examples o f primary prevention in relation to heart failure
would include interventions to prevent these diseases. These interventions include
following a low fat diet, daily exercising, and enrolling in a weight loss or smoking
cessation program, in order to prevent heart disease.
Secondary prevention involves interventions or treatment after symptoms o f stress
have occurred. Secondary prevention is the active treatment o f actual stressors.
Secondary prevention could be hospitalization for treatment o f heart failure symptoms.
These symptoms may be treated with pharmacological interventions, surgical
interventions, or lifestyle changes, such as diet and activity.
Tertiary prevention focuses on readjustment toward optimal client system stability
after active treatment or secondary prevention has occurred. Tertiary prevention assists in
reconstitution. Reconstitution is the state o f adaptation to stressors in the internal and
external environment (Neuman & Fawcett, 2002). Tertiary prevention would focus on re
education o f the heart failure patient to help prevent recurrence o f heart failure
symptoms. Tertiary prevention leads back to primary prevention, in that the goal is to
again strengthen the lines o f defense, so that a reaction does not occur again.
An example of tertiary prevention is the nursing care provided in the home
through a home care agency after a heart failure patient is newly diagnosed or after the

11

patient has recently been discharged from the hospital. Home care can assist in providing
support and education related to the patient’s disease state. As the patient’s variables
start to interact in a more positive manner due to tertiary prevention, the patient becomes
more stable. This stability should decrease symptoms and increase the patients’
perception of quality o f life, thereby allowing reconstitution to occur.
Variables
Important concepts from Neuman’s systems model that relate to the study
variables o f this research are client, stressor, reaction, tertiary prevention, and
reconstitution (see Figure 2). The client is the patient with heart failure with five
variables interacting together to maintain stability. As heart failure and its characteristics
become a stressor, this causes instability o f the five client variables. This stressor, heart
failure, breaks down the lines o f defense causing a reaction, which is decreased quality o f
life. W hen a reaction occurs, nurses need to apply a tertiary prevention intervention, in
order to reeducate the patient to prevent future occurrences and to attain optimal
wellness. An example o f tertiary prevention is a supportive educational intervention in
the patient’s home. Reconstitution occurs as tertiary prevention reduces further stress
reaction by increasing the patient’s quality o f life.
Review o f Literature
The major concepts o f this study are quality o f life and heart failure, and how they relate
to each other. In the literature, the terms quality o f life (QOL) and health related quality
o f life (HRQOL) are frequently used interchangeably. For the purpose o f this research,
health-related quality o f life and quality o f life will be considered the same concept.
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Quality o f Life in the Patient With Heart Failure
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Quality o f Life Research
Quality o f life research is not a new research subject. According to Kinney,
Burfitt, Stullenbaarger, Rees, and DeBolt (1996), publications with quality o f life in their
title increased from 200 in 1980, to 2100 in 1994. Testa and Simonson (1996) referenced
“quality o f life” as the key words in 5 articles from the Medline data base in 1973. In
1994, the same authors were able to reference 1252 articles with the key word “quality o f
life.”
There are many issues surrounding quality o f life research. One o f these issues is
that there is not a consensus on the conceptualization or the defrnition of quality o f life.
Quality o f life conceptualizations and definitions are numerous and multidimensional.
Another issue is that there is not a consensus on how to measure quality o f life. There are
multiple instruments that measure different definitions o f quality o f life. Therefore, these
two issues make it difficult to compare results across studies.
Testa and Simonson (1996) conceptualize quality o f life and health related quality
o f life as the physical, psychological, and social domains o f health, seen as distinct areas
that are influenced by a person’s experiences, beliefs, expectations and perceptions.
Keister and Blixen (1998) conceptualize quality o f life as an “elusive phenomenon,”
encompassing biological, interpersonal, social, economic, and cultural dimensions.
Farquhar (1995) developed a taxonomy o f quality o f life definitions - global definitions,
component definitions, focused definitions, and combination definitions. The ability to
develop a taxonomy shows the complexity and difficulty in the utilization o f the term
quality o f life.
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Ferrans has published multiple articles on quality o f life related to chronic
illnesses such as cancer, renal failure, and heart failure ( 1990, 1992). She has also
developed the Quality o f Life Index instrument. Ferrans groups the definition o f
“quality o f life” into five categories; normal life, happiness/satisfaction, achievement of
personal goals, social utility, and natural capacity. Ferrans also lists examples o f various
dimensions frequently used to measure quality o f life. They are health and physical
functioning, psychological/spiritual variables, social/economic variables, and family.
The use of multiple measures o f quality o f life presents with problems.
According to Kinney (1995), use o f different and multiple instruments do not allow
comparison o f results across studies and these measures seldom undergo psychometric
evaluation. In the measurement o f quality o f life, researchers use study-specific measures
in order to capture the outcomes o f the specific study, not allowing for comparison o f
results. Kinney reviewed 84 descriptive studies and 84 experimental studies in her meta
analysis o f quality o f life publications and discovered that 75% o f the descriptive studies
and 71% o f the experimental studies failed to address the issues o f validity, reliability and
sensitivity.
The measurement and evaluation o f quality o f life has become increasingly
important in health care practice, research, and social policies. As advances in care and
technology continue, quality o f life measurement can assist in decisions about treatment
by evaluating the benefits and costs o f these new interventions. This is important
particularly in a disease such as heart failure, with its high morbidity and mortality, and
escalation o f new cases. It is apparent that quality of life is an important clinical outcome
when measuring health outcomes. The Agency for Health Care Policy and Research
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(AHCPR) determined that the number one recommendation related for research o f health
outcomes is the need to reduce mortality and improve quality o f life (Hadom, Baker,
Dracup, & Pitt, 1994). The Heart Failure Guideline Panel, sponsored by the AHCPR,
decided that relevant outcomes are those experienced directly by patients, such as
mortality and quality o f life, and that evaluating changes in only biochemical,
physiological, anatomical, or histological outcomes were insufficient (Hadom et al.,
1994).
Descriptive Research Involving Oualitv o f Life and Heart Failure
There are numerous studies with the key words o f heart failure and quality o f life
(Chin & Goldman, 1998; Cline, Willenheimer, Erhardt, Wiklund, & Israelsson, 1999;
Dracup, Walden, Stevenson, & Brecht, 1992; Grady, 1993; Jaagosild et al., 1998;
Kinney, 1995; Kinney, et al 1996; Leidy, Rents, & Zycynski, 1999; M oser & Worster,
2000; Muirhead et al., 1992; Riedinger et al., 2001; Shively, Fox, & Brass-Mynderse,
1996; Van Jaarsveld, Sanderman, Miedema, Ranchor, and Kempen, 2001; Walden et al.,
1994). Six o f these publications analyzed multiple studies of quality o f life and heart
failure. Ferrans (1992) examined 22 studies on the conceptualization o f quality o f life in
patients with cardiovascular disorders. Grady (1993) likewise examined the definition of
quality o f life, conceptual frameworks, and commonly used measurement instruments
and outcomes in medically and surgically managed patients with heart failure. Kinney et
al. (1996) analyzed 84 studies o f quality o f life in cardiac patients published during the
periods o f 1987 and 1991. Shively et al. (1996) too reviewed eight studies measuring
health-related quality o f life in medically managed heart failure patients. Leidy et al.
(1999) also examined outcomes o f 46 studies that involved randomized, controlled
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treatment trials o f heart failure. Moser and W orster (2000) reviewed five studies linking
psychosocial variables to morbidity and mortality outcomes in patients with heart failure.
After review o f these studies, Ferrans (1992), Grady (1993), Kinney et al. (1996),
Shively et al. (1996), and Leidy et al. (1999) discovered sim ilar issues and findings
within quality o f life descriptions and heart failure. All five articles discuss the need for
quality o f life to be defined and conceptualized as it relates to heart failure, since it has
become a common focus o f research. Three o f the four studies, Kinney et al., Grady,
and Leidy et al. found that there were small positive effects o f treatment on quality o f
life, in regards to symptomology, functional ability and overall quality o f life. Most o f the
studies found that the primary domain affected by treatment o r symptoms is the
performance o f activities o f daily living (ADLs). The authors o f these studies agree that
more critical analysis o f the approach to research related to quality o f life in cardiac
patients is needed. Two o f the studies, Kinney et al. and Leidy et al., suggest more
studies need to be done on family member’s perspective or health care provider to
supplement the evaluation o f quality o f life
Four recent studies (Cline et al., 1999; Dracup et al., 1992; Muirhead et al., 1992;
Walden et al., 1994) assessed the heart failure patient’s quality o f life using various
measures and subjects. Dracup et al. measured the quality o f life of 134 patients with
symptoms of advanced heart failure being evaluated for a possible heart transplant and
measured three dimensions o f quality o f life, which were functional capabilities,
symptoms, and psychosocial perceptions. Instruments utilized to measure functional
capabilities were the Heart Failure Functional Status Inventory (HFFSI) and the sixminute walk. Instruments utilized to measure psychosocial perceptions were the Multiple
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Affect Adjective Checklist (MAACL) and the Pyschosocial Adaptation to Illness Scale
(PAIS). Instruments utilized to measure symptoms were the New York Heart
Association class and the HFFSI. The New York Heart Association (NYHA) functional
capacity classification is frequently used when defining severity o f heart failure and is
shown in Table 1 (Borsody, Coumey, Taylor, & Jairath, 1999).
Table 1
NYHA Functional Classifications

Class

Description

Class I

Patients with cardiac disease but without resulting limitations o f
physical activity. Ordinary physical activity does not cause undue
fatigue, palpitation, dyspnea, or anginal pain.

Class II

Patients with cardiac disease resulting in slight limitations o f
physical activity. They are comfortable at rest. Ordinary physical
activity results in fatigue, palpitation, dyspnea, or anginal pain.

Class III

Patients with cardiac disease resulting in marked limitation o f
physical activity. They are comfortable at rest. Less than ordinary
activity causes fatigue, palpitation, dyspnea, or anginal pain.

Class IV

Patients with cardiac disease resulting in inability to carry out any
physical activity without discomfort. Symptoms of heart failure or
the anginal syndrome may be present even at rest. If any physical
activity is undertaken, discomfort is increased.

Muirhead et al. (1992) assessed coping and quality o f life in 41 patients with
advanced heart failure awaiting heart transplantation. The instruments utilized were the
Profile o f Mood States (POM S), the Dyadic Adjustment Scale (DAS), a symptom/feeling
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checklist, a 44-question quality o f life scale, Derogatis’ Symptom Checklist-90-Revised
(SCL-90-R), and the Folkman and Lazarus’ Ways o f Coping Checklist.
Walden et al. (1994) assessed the quality o f life o f 31 patients with heart failure 12 patients with advanced heart failure stabilized with medical therapy and 19 patients
who had undergone heart transplantation. These patients were assessed at two different
time frames - at time o f heart transplantation evaluation and 41 months later. Quality o f
life was measured utilizing the Multiple Affect Adjective Checklist (MAACL), the
Psychosocial Adjustment to Illness Scale (PAIS), and the Heart Failure Functional Status
Inventory (HFFSI).
Cline et al. (1999) assessed quality o f life in 191 elderly patients with heart
failure. The instruments utilized to measure quality o f life were the Nottingham Health
Profile (NHP), the Quality o f Life Questionnaire in Heart Failure, and the Patient’s
Global Self- Assessment.
The patients in all four studies (Cline et al., 1999; Dracup et al., 1992; Muirhead
et al., 1992; Walden et al., 1994) described their quality o f life as compromised, negative,
or poor. Dracup et al., Muirhead et al., and Walden et al. also discovered that these
patients had varying degrees o f anxiety, depression, hostility, and similar symptoms
causing major limitations, such as fatigue, shortness o f breath, and weakness.
Two o f the above studies correlated quality o f life and clinical variables (Cline et
al., 1999; Dracup et al., 1992). Both studies looked at ejection fractions, age, gender, and
marital status and how these variables correlate with quality o f life. In the Cline et al.
study, three instruments were used to measure quality o f life, the Patients’ Global SelfAssessment (PGSA), the Nottingham Health Profile (NHP) and the Quality o f Life
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Questionnaire in Heart Failure (QLQ-HF). There are significant correlations with total
quality o f life scores using these three measures (p = < .001). The authors reported a
very strong correlation between the QLQ-HF and the PGSA (r = 0.80), with moderate
correlations between the QLQ-HF and the NHP (r = 0.65), and between the PGSA and
the NHP (r = 0.59).
A relationship between quality o f life and the New York Heart Association class
(NYHA) was found in the Cline et al. (1999) study utilizing the NHP and the QLQ-HF.
According to the results, the higher the NYHA class, the poorer the quality o f life (NHP,
p< 0.001; QLQ-HF, p< 0.01).
Dracup et al. (1992) correlated ejection fractions, metabolic equivalents to the
task (METs) level and 6-minute walk. The 6-minute walk results significantly correlated
with the patients’ self-reported MET level (r = -0.60, p<0.001) and with the New York
Heart Association class (r = -0.46, p<0.001).
Cline et al. (1999) also found a significant finding in regard to age. The oldest
age group, ages 80-84, reported less interference between their health and their hobbies
or interests (p< 0.01). Quality o f life was poorer in women as compared to men in the
total scores o f all three instruments utilized: the NHP (37.6 + 21.0 vs. 25.8 ± 19.7,
pcO.OOl), the QLQ-HF (4.7 + 0.9 vs. 1.0 + 1.1, pcO.OOl), and the Patient’s Global SelfAssessment (4.5 + 1.3 vs. 3.8 ± 1.6, p<0.001).
Riedinger et al. (2001) evaluated gender differences in quality o f life and heart
failure utilizing secondary data from the Studies o f Left Ventricular Dysfunction
(SOLVD) trials. The sample compared 691 women with 691 men. The instruments used
to assess quality o f life were the Ladder o f Life, Profile o f Mood States Inventory,
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Functional Status Questionnaire, Symptoms Scale, and one item from the Medical
Outcomes Study - perception of general health. Women had significantly worse quality
o f life ratings than men for intermediate ADLs (30.77 ± 13.52 vs. 37.34 ± 11.60,
p< 0 0 0 1) and social activity (77.22 ± 29.47 vs. 86.16 ± 26.17, p< .008) after adjusting
for the NYHA classification (Riedinger et al., 2001).
M oser and W orster (2000) suggest that psychosocial factors, particularly lack o f
social support and depression, are associated w ith poorer outcomes in cardiac patients. In
the limited publications that studied psychosocial variables and quality o f life, there is
evidence that relates poor quality o f life, social isolation, lack o f emotional support,
anxiety, depression, morbidity, and mortality. M oser and Worster agree that quality o f
life is a multidimensional concept, but many studies define it as unidimensional, focusing
on physical functioning and symptoms, leaving out the psychosocial piece o f quality of
life.
One limitation o f the studies done by Muirhead et al. (1992), Riedinger et al.
(2001), and Walden et al. (1994) is that it is difficult to generalize the results. Muirhead
et al. had possible bias due to the fact that the patients that underwent transplantation
quickly or who were too ill to complete the lengthy questionnaires were not included, and
the mean age o f 48 seems to be much lower than the mean ages o f other studies. Walden
et al. had a response rate o f 40% to 59% at baseline and at 3!6-year follow-up, causing a
potential bias due to the small number o f patients responding to the questionnaires.
Walden et al. also had another potential bias regarding the large number o f deaths from
heart failure (64%) compared with deaths related to heart transplantation (34%), being
that only the survivors completed the questionnaires. Muirhead et al. and Walden et al.
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both had small sample sizes. A limitation o f a secondary analysis study, such as the
study that Riedinger et al. (2001) did is that the research is limited to studying the
available data.
Longitudinal Research Involving Oualitv o f Life and Heart Failure
Two recent studies by Van Jaarsveld et al. (2001) and Jaagosild et al. (1998)
studied quality o f life over time. Both Van Jaarsveld et al. and Jaagosild et al. were part
o f larger studies. Van Jaarsveld et al. collected their initial data from a community-based
survey, the Groningen Longitudinal Aging Study (GLAS), which was a population-based
prospective study. The GLAS had a baseline population comprised o f 5,279 subjects.
Jaagosild et al. pulled their patient sample from the Study to Understand Prognosis and
Preferences for Outcomes and Risks o f Treatments (SUPPORT), which was a prospective
5-center study. The SUPPORT study had a baseline population of 9,105 patients.
Van Jaarsveld et al. (2001) studied two patient populations, older adult patients
with an acute myocardial infarction or with a diagnosis o f heart failure. Premorbid data
were collected from the original study. After baseline data were collected (TO), 207
patients with a new episode o f an acute myocardial infarction with 292 patients with a
new diagnosis o f heart failure were followed for 12 months after diagnosis. Changes in
quality o f life were measured at 6 weeks after diagnosis (T l), at 6 months (T2), and at 12
months (T3). The outcome measures for quality o f life were conceptualized as the three
domains relating to functioning - physical, psychological, and social. The measurement
tool used to assess physical functioning was the Groningen Activity Restriction Scale
(GARS). The tool used to assess psychological function, mainly symptoms o f depression
and anxiety, was the Hospital Anxiety and Depression Scale (HADS). Two subscales
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from the Medical Outcomes Study (MGS) Short Form were used to assess social
functioning.
In comparing the premorbid quality o f life o f the reference group, the acute
myocardial group, and the heart failure group, the heart failure patients started out with a
poorer quality o f life, except for anxiety (Van Jaarsveld et al., 2001). Van Jaarsveld et al.
discovered a relationship between physical functioning and heart failure. At the 6-week
time frame, physical functioning had worsened and remained worse at the 12-month time
frame. The changes from premorbid to 6 weeks after diagnosis and the change between
time frame 1 and time frame 3 were significant (ES = .90, p< .05).
Van Jaarsveld et al. (2001) also discovered that the psychological functioning
results in the heart failure patient were significantly lower (p< .05). Mean levels o f
anxiety increased over time and remained elevated at the 12-month time frame. Heart
failure patients did not experience depression until 6 and 12 months after diagnosis.
Social functioning mean scores increased at each time frame for the heart failure patients,
as did role functioning mean scores. These increases in scores showed significant
worsening in the quality o f life measures in regard to the psychological functioning
domains o f anxiety (ES = .32, p< .05), social functioning (ES = .37, p< .05), and role
functioning (ES = .37, p< .05).
According to Van Jaarsveld et al. (2001) there were limitations to this study.
Some o f the changes in the quality o f life o f patients with heart failure could be due to
aging and other morbidity causes. Since the responders to the larger GLAS study were
younger, more often male, and had better baseline physical functioning and less
comorbidity than the non-responders, the effects o f heart failure may be larger on the
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total population, since the responders seemed to be less limited.

Also the study does not

include longitudinal data on the reference group, therefore the quality o f life changes may
not be due to heart failure.
Jaagosild et al. (1998) studied quality o f life, resource use and survival o f the
patient with acute exacerbation o f severe heart failure. Out o f 9105 patient enrolled in
the SUPPORT study, 1390 patients met the inclusion criteria for the Jaagosild study.
Jaagosild et al. utilized the following instruments: The Acute Physiology Score
component o f the Acute Physiology and Chronic Health Evaluation III, measuring the
patients’ physiologic status; the G lasgow Coma Scale, assessing the patients’ neurologic
status; the Duke Activity Status Index, measuring the patients’ activity status; the
Sickness Impact Profile, measuring perceived health status; the Katz Index of Activities
o f Daily Living, measuring the patients’ functional status.
Jaagosild et al. also assessed health perception with the use o f two general health
status scales. One of the scales involved having the patient rate their overall QOL as
excellent, very good, good, fair, o r poor. The other health status scale involved having
the patient rate their current state o f health on a scale from 0 (death) to 100 (excellent
health). Health utility was measured by the time-tradeoff technique. The time frames o f
data collection were at admission into the study (hospitalization with acute exacerbation
o f heart failure), at 60 days after admission and then at 180 days after admission.
The two purposes o f the Jaagosild et al. (1998) study w ere to determine mortality
and quality o f life outcomes over time. Ninety three percent o f the patients survived their
hospital stay, 90.3% survived to 30 days post hospitalization, 83.8% survived to 60 days
post hospitalization, 72.9% survived 180 days, and 61.5% survived at I year. Where the
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patients returned after the acute episode o f heart failure, 92.6% returned home, 3 .1%
were discharged to a nursing home, 0.5% to a hospice program, 2.3% to a rehabilitation
hospital, and 1.6% to another acute care hospital. Overall quality o f life was rated as
excellent, very good, or good in 35 .7% o f patients at admission, 49.3% at 60 days (p<
.001), and 58.2% at 180 days (p< .001).
Both Jaagoslid et al. (1998) and Van Jaarsveld et al. (2001) found statistically
significant results related to the change o f quality o f life over time, but the results were
different. The quality o f life for the patients in the Jaagoslid et al. study improved (p<
.001), whereas the quality o f life for the patients in the Van Jaarsveld et al. study
worsened. Variables that may have made the difference in the two studies were that the
demographics o f the heart failure study populations were slightly different. More men
participated in the Jaagoslid et al. study (62%) when compared to the Van Jaarsveld et al.
study (41%). The mean age o f patients in the Van Jaarsveld et al. study was 75 versus
mean age o f 68 in the Jaagoslid et al. study.
Another difference in the two studies (Jaagoslid et al., 1998, Van Jaarsveld et al.,
2001) is how the patients were enrolled in the study in relation to the diagnosis o f heart
failure and the length of time that the data was collected. Data collection for Van
Jaarsveld et al. began prior to diagnosis o f heart failure and then continued until 12
months after diagnosis. The period between the baseline measurement and diagnoses o f
heart failure ranged from 1 month to 58 months, averaging 26 months for the heart failure
patient. Data collection for Jaagoslid et al. began at admission to the hospital with an
acute exacerbation o f heart failure, at 60 days post admission, and at 180 days post
admission. The measurement period for the Jaagoslid et al. study was 6 months. Since
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the Van Jaarsveld et al. study was over a much longer time frame than the Jaagoslid et al.
study, this could account for the different results.
Chin and Goldman (1998) examined gender differences in the processes o f care
and quality o f life o f patients with heart failure from the time o f admission to the hospital
until 1 year after discharge. There were 435 patients admitted to the study and the time
frames involved were at admission to the hospital with heart failure, two months after
discharge and then one year after discharge. The instrument used to measure quality o f
life was the MOS Short Form-36. In relation to mortality, 77% o f the patients survived
past the first year, and the rates were similar for both genders. Chin and Goldm an’s
mortality findings are slightly higher than the Jaagoslid et al. (1998) findings.
Chin and Goldm an’s research was consistent with most o f the studies related to
low quality o f life baseline scores, but women had lower scores than men for vitality,
physical function, and their physical component summary scores (PCS) were also lower
(p< 0.05). The Dracup et al. (1992) study did not find any gender differences in quality
o f life scores, but the sample was only 17% female, whereas Chin and Goldm an’s sample
was 50% women. At the 2-month time frame, women continued to have lower scores
than men for health perception, vitality, physical function, social function, and PCS
(p^O 05). Women continued to have lower scores at the 1-year time frame in all
domains measured except role mental function and mental component scale (MGS).
According to Chin and Goldman, limitations o f this study were that the findings
may not be general izable because it was done at one urban academic medical center and
that they may not have adjusted for all confounding factors across gender, despite their
use o f multivariate regression techniques and stratification.
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Known limitations with longitudinal studies utilizing surveys are missing data and
non-response. Even though most researchers do careful non-response analyses, response
bias is always a factor. Polit and Hungler (1999) state that the most serious problem with
longitudinal studies is attrition, the loss o f participants at different points in the study.
Correlational Research Involving Oualitv o f Life and Heart Failure
Konstam et al. (1996) examined the relationship o f quality of life to mortality in
the heart failure patient. This was a substudy o f The Studies o f Left Ventricular
Dysfunction (SOLVD). SOLVD had a study population o f 6,797 subjects from 23
centers. These patients were randomized to receive double-blind enalapril or placebo to
evaluate the effects on patients with heart failure.
The quality o f life assessment utilized by Kostam et al. (1996) was a self-report
questionnaire selected from a battery o f instruments, with demonstrated validity and
reliability. The questionnaire assessed physical functioning, emotional distress, social
health, intimacy, life satisfaction, perceived health and productivity. The study found
that quality o f life significantly influenced the relative risk o f mortality. Utilizing a
multivariate model, independent predicators o f mortality are heart failure symptoms
(p<0.025), activities o f daily living (pcO.OOO), and general health (p<0.000). Needed
refinement of the quality o f life questionnaire and the degree o f missing quality o f life
data during follow-up are limitations o f this study.
Grady et al. (1995) studied 359 patients with advanced heart failure who were
awaiting heart transplantation. Grady et al. examined life satisfaction, correlation o f life
satisfaction, and predictors o f quality o f life utilizing eight instruments. The Quality o f
Life Index by Ferrans and Powers was used to determine life satisfaction. The top five
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items that the patients were most satisfied with were health care, emotional support from
others, children, family’s health, relationship with spouse or partner, with mean scores
ranging from 5.02 to 5.62. The top five items that the patients were least satisfied with
were current health status, ability to travel, energy for daily activities, ability to do things
around the house, sex life, with mean scores ranging from 2.40 to 3.74.
Grady et al. (1995) also found a significant correlation o f overall life satisfaction
to demographic, physiologic, and psychosocial variables. Life satisfaction was correlated
with older age (r = 0.13, p = 0.008) and lower New York Heart Association functional
classification, (r = -0 16, p = 0.001). These were the same results that Dracup et al.
(1992) and Cline at al. (1999) found. Fewer daily medications were also significantly
correlated (r = -0.16, p = 0.001) to life satisfaction. Overall life satisfaction was
significantly related to less overall symptom distress (r = -0.44, p < 0.001), moderately
correlated with less stress overall (r = -0.49, p = ^0.0001), and coping (r = 0.31, p =<
0 . 0001 ).

Grady et al. (1995) found significant predictors o f higher quality o f life in the
study population. By performing stepwise multiple regression, utilizing overall life
satisfaction as the dependent variable and 19 independent variables, 11 o f the 19
variables were significant predictors o f overall life satisfaction (p < 0.0001). Symptom
distress was the highest variable (r = -0.44, F - 84.75), which accounted for 19% of the
variance.
Friedman and Griffin (2001) found that physical symptoms and physical
functioning correlated with depression, one o f the frequently studied psychosocial
variables related to quality o f life. The sample group for this study was 170 patients with
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heart failure. Data were collected per interview at two different time frames, the time of
hospitalization and 4-6 weeks after discharge. The instruments utilized were a 13-item
symptom checklist generated from the list o f heart failure symptoms contained in the
Agency for Health Care Policy Research 1994 publication, a lO-item physical
functioning scale from the MOS Short Form Health Survey, the lO-item depression
CES-D scale Short Form, medical history, and sociodemographic data. Physical
symptoms (r = 0.48) and physical functioning (r = -0.32) were moderately correlated with
depression, and physical symptoms contributed to 13% o f the variance in depression and
physical functioning contributing only 2%.
Mayou, Blackwood, Bryant, and Gamham (1991) studied the relationship
between exercise capacity, symptoms, and quality o f life. The study sample consisted of
123 patients, classified as New York Heart Association Class II or III, with a median age
of 60 years old. The instruments utilized for measuring quality o f life were a 5-point
Likert scale o f “best to worse” on 11 variable symptoms, the Profile o f Moods State and
interview ratings from a questionnaire developed and shown to be reliable in previous
cardiac research, and patient diaries.
Mayou et al.’s (1991) top three physical symptoms from the 5-point Likert scale
measurement were tiredness, breathlessness, and chest pain. Tiredness and breathlessness
are similar to findings from other studies, such as Dracup et al.(I992), Walden et al.
(1994), Muirhead et al. (1992), and Friedman and Griffin (2001).

Mayou et al. also

examined associations between exercise capacity and quality o f life symptom
measurement and quality o f life interview.

Statistically significant differences were

present associating poor exercise capacity with more symptoms and limitations. Those
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that did the least well on the treadmill suffered more tiredness (p < 0.005,) and difficulty
sleeping (p< 0.005), inability to walk quickly (p< 0.001), and were unable to perform
daily tasks quickly ( p< 0 . 01 ). The patients that did poorly on the treadmill also reported
limitations with leisure (p< 0.05) and sex (p< 0.05).
Mayou et al. (1991) also examined the relationship between changes in exercise
capacity and quality o f life. Over a three-month period, regression analysis showed
significant positive relationships between Likert symptom scores and ability to walk and
perform daily tasks (F = 31.77, p<0.00l).
Therapeutic Treatment Research Involving Oualitv o f Life and Heart Failure
Leidy, Rents, and Zycynski (1999) evaluated quality o f life outcomes in patients
with heart failure in randomized controlled trials. Pharmacological and nonpharmacological treatments were reviewed. Forty-one studies were actually reviewed,
with 30 of the 41 studies evaluating a pharmaceutical agent, and the remaining 11
evaluating the impact o f physical exercise, nasal continuous positive airway pressure
treatment during sleep, nurse-managed care and primary care on quality o f life. The
overall reviews o f these studies showed that both treatment types have a positive impact
on quality of life. The pharmacological treatments improved overall quality o f life, with
the domains o f symptoms and physical activity being the most sensitive. The nonpharmacological treatments suggested that they improve quality o f life, but were more
elusive.
Pharmacological treatments and interventions. Rogers et al. (1994) were
investigators for The Study o f Left Ventricular Dysfunction (SOLVD). This study
assessed the quality o f life o f patients with left ventricular dysfunction for 2 years after
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randomization to enalapril, an angiotensin-converting enzyme inhibitor, or placebo. The
main aim o f the SOLVD study was to compare the effect o f enalapril and placebo on
mortality, with a subsequent study on the effects o f treatment on quality o f life. The
study population consisted o f 5,025 patients randomized into either the treatment group
or the placebo group. All patients completed a questionnaire at randomization, at 6
weeks, at I year and at 2 years o f follow-up. The questionnaire contained 14 scales,
excerpted from previously validated instruments addressing 7 components o f quality of
life: physical functioning, emotional distress, social health, intimacy, life satisfaction,
perceived health, and productivity o f job performance.
Quality o f life scores were significantly better with enalapril group in two
consecutive follow-up intervals, six weeks (TF2) and I year (TF3) in two areas, social
functioning and dyspnea. The enalapril group had improved dyspnea at 6 weeks (p =
0.002), with a mean o f 2.03 as compared to the placebo group with 2.28, and at 1 year
(p= 0.0003), with a mean o f 2.09 as compared to the placebo group with 2.29. The
enalapril group also had improved social functioning at 6 weeks, with a mean o f 1.48 as
compared to the placebo group with 1.57 (p = 0.0003), and at 1 year with a mean o f 1.45
as compared to the placebo group with 1.54 (p = 0.02). The main limitation with this
study is the significant extent o f missing data during follow-up. The missing data were
related to non-survivors and failure to complete the survey.
Rector and Cohn (1992) enrolled 198 patients with a diagnosis o f heart failure in
order to determine the reliability and validity o f the M innesota Living with Heart Failure
(LlhFE) questionnaire. Rector and Cohn’s study involved a randomized, double-blind,
placebo-controlled, 3 month trial o f pimobendan, which is an investigational medication
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with inotropic and vasodilator effects. The oral pimobendan was administered at 3
different doses - 2.5mg, S.Omg, and lOmg daily. The LlhFE questionnaire, an exercise
test, and patient ratings o f dyspnea and fatigue measured the patient’s quality o f life. The
questionnaire was administered at baseline, and at 4, 8, and 12 weeks after
randomization.
The results o f this study showed significant improvement in the total quality o f
life score with the 5mg pimobendan dose as compared with the placebo (Cl = 0, 18; p =
0.01 ) and with the physical dimension (Cl = 0, 8; p = 0.01). There were also weakly
related changes in the total (r =0.33; p< 0.01) and physical (r =0.35; p< 0.01) quality o f
life scores to exercise times, which corresponded with changes in patients’ ratings o f
dyspnea and fatigue.
Non-oharmacological treatments and interventions. Four recent publications
studied the use of non-pharmacological interventions on functional status and quality o f
life, which are frequently studied together as variables (Belardinelli, Georgiou, Cianci, &
Purcaro, 1999; Fonarow et al., 1997; Kostis, Rosen, Cosgrove, Shindler, & Wilson, 1994;
Oka et al., 2000). All four o f the studies incorporated some type o f exercise training
within their studies. The results in the studies by Fonarow et al., Kostis et al. and
Belardinelli et al. showed that exercise training had a positive effect on quality o f life.
Kostis et al. also examined mood changes with positive results.
Fonarow et al. (1997) developed a comprehensive heart failure management
program that included medical and non-medical treatments and then assessed the impact
o f this program on hospital costs, hospital readmission rates, and functional status. The
program included changes in the patient’s medical regimen after right heart
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catheterization and pulmonary pressure monitoring. The changes in the patient’s medical
regimen consisted o f a 98% increase in angiotensin-converting enzyme inhibitor dose and
a flexible diuretic regimen. The non-medical part o f the program included
comprehensive patient education. This education was taught by a heart failure clinical
nurse specialist, either in group and/or individual sessions. The educational content
included information about diet, progressive exercise, and self-monitoring. Two hundred
and fourteen heart failure patients being evaluated for transplantation participated in the
study over a three-year period. The New York Heart Association classification and peak
oxygen consumption testing assessed functional status.
Fonarow et al.’s (1997) study results showed a significant improvement in
functional status six months after the program was initiated. At six months, 179 patients
had not received a transplant, who were classified as a New York Heart Association
functional class o f III or IV at the start o f the study. At six months, 49% o f these patients
increased to a New York Heart Association functional class of I or II (p < 0.001). There
were 35 additional patients that were dying or had received a transplant. When these
patients were included with the 179 other patients, as a functional class IV, the
improvement remained significant (p < 0.01). Peak oxygen consumption could be
measured in 72% o f the study sample and a significant increase was present (15 .2 vs.
11.0 ml/kg per min., p < 0.001 ).
The study by Kostis et al. (1994) also resulted in non-pharmacological therapy in
improving functional status, along with emotional status improvement in the heart failure
patient. Kostis et al. compared a multimodal non-pharmacological intervention,
consisting o f an intensive life-style modification program, to digoxin and placebo in 20
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patients with mild heart failure, with a New York Heart Association class o f 11 (n=19) or
III (n=l). The non-pharmacological program included structured exercise, dietary
modifications, and cognitive-behavioral therapy for a 12-week period. The patients were
randomly assigned to one o f the three treatment groups and were monitored over a 12week period. Measurement instruments included the following: selected physical
symptoms such as dyspnea, fatigue, evidence o f rales, edema, third heart sound, neck
vein distention, hepatomegaly; modified Naughton protocol treadmill exercise testing;
echocardiography; 6-minute walk test; the Anxiety Disorders Interview ScheduleRevised and the Beck Depression Inventory; the Hamilton Scales.
At baseline, there were no significant differences among the three groups that
Kostis et al. (1994) compared. There were significant improvements within the nonpharmacological therapy group as compared to the digoxin and placebo groups. One
significant improvement was exercise tolerance on the treadmill test (p< 0.05) when
comparing the nonpharmacologic group (182 ± 139) to the digoxin group (5 1 ± 50).
There was also significant improvement with weight loss(p< 0.05) when comparing the
nonpharmacologic group (-4.37 + 4.50 kg) to the digoxin group (0.32 ± 1.76 kg,).
Both the digoxin and the placebo groups deteriorated in the mood change
variables as compared to the nonpharmacologic group. Anxiety scores improved
significantly (p< 0.05) in the nonpharmacologic group (5.0 ± 5.0) as compared to the
placebo group (3.0+6.8) and the digoxin group (-5.2 + 5.4). Depression scores also
improved significantly (p< 0.05) in the nonpharmacologic group (5.0 + 5.0) as compared
to the placebo group (1.0 + 4.9) and the digoxin group (-6.6+ 10.1). The digoxin group
did have significant improvement (p< 0.05) in ejection fraction (4.4 ±6.5) when
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compared to the placebo group (-1.2 ± 3.9) and non-pharmacological group (-3.2 ± 3.9)
without improvement in the quality o f life measures.
Belardinelli et al. (1999) also studied how exercise training affects functional
status and quality o f life in the heart failure patient. Belardinelli et al. took 99 patients
with heart failure and randomized them into two groups. One group participated in an
exercise program two times a week for one year, while the other group did not exercise.
Functional status was measured with a cardiopulmonary exercise test and thallium
scintigraphy, and was measured at baseline, 2 months, and 14 months. Quality o f life
was assessed utilizing the Minnesota Living With Heart Failure Questionnaire at 2, 14,
and 26 months. The only significant changes for functional status or quality o f life were
within the exercise group. Functional status improved at 2 months (p< 0.001 ) and did not
change at any other points in time. Quality o f life score improved significantly in the
exercise group (r = 0.80, p< 0.001) after 2 months and remained stable throughout the
rest o f the exercise program and follow-up.
Oka et al. (2000) examined the efficacy o f a home-based exercise program on
heart failure in relation to the patient’s symptoms, dyspnea and fatigue, and also on the
quality o f life domains o f emotional function and mastery. Forty heart failure patients
with a New York Heart Association class o f II or III were the study population. The
patients were randomly placed in two groups. One group received three months o f usual
care, and the other group received home-based walking and resistance exercise training.
Exercise capacity was measured by a treadmill exercise test using a modified Naughton
protocol to determine peak oxygen uptake as did Kostis et al. (1994). The symptoms o f
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dyspnea and fatigue, along with quality o f life, were measured with the Chronic Heart
Failure questionnaire. These variables were measured at baseline and at 3 months.
Oka et al.’s (2000) study results observed no differences in sample characteristics
between the two groups and no significant differences in exercise capacity between the
two groups. These findings are inconsistent with Kostis et al. (1994), Fonarow et al.
(1997), and Belardinelli et al. (1999) who all found significant changes in relation to
exercise capacity. Oka et al. did find significant results with the exercise group, which
were improved fatigue (F (1,74) = 6.66; p< 0.02), and improved emotional function
(F (1,220) = 7.93; p< 0.01).
Rich et al. (1995) conducted an experimental study on 282 heart failure patients to
assess the effects o f a nurse-directed intervention on hospital readmission rates, quality o f
life, and costs o f care. The patients were randomized into a control group and
experimental group. The control group received conventional care and the experimental
group received an intervention that consisted o f comprehensive education o f the patient
and family, a prescribed diet, social-service consultation and planning for an early
discharge, a review o f medications, and intensive follow-up. Quality o f life was
measured utilizing the Chronic Heart Failure Questionnaire and the time frames assessed
were at baseline and at 3 months. Out o f the 282 patients that participated in the study,
126 had the quality o f life questionnaires administered to them. There were 59 patients in
the control group with 67 patients in the experimental group.
According to the results o f Rich et al.’s (1995) study, quality o f life significantly
improved more in the experimental group than the control group (22.1 ± 20.8 vs. 11.3 +
16.4, p< 0.001), even though quality o f life scores improved over time in both groups.
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The experimental group also had a significant increase over the control group in three
sub scales o f the quality o f life questionnaire; dypsnea (6.8 ± 7.9 vs. 3.8 ± 5.4, p< 0.01),
fatigue (5.4 + 5.5 vs. 2.7 ± 6 1, p< 0.01), and emotional function (5.6 ± 7.1 vs. 1.9 + 5.2,
p< 0.001)
Jaarsma et al. (2000) conducted an experimental study on 179 patients with
advanced heart failure. New York Heart Association classification III and IV, to
determine the effects o f a supportive educational nursing intervention on self-care
abilities, self-care behavior, and quality o f life. Functional capabilities, symptoms, and
psychosocial adjustment to illness were the three dimensions o f quality o f life that were
examined. Functional capabilities were measured utilizing the Heart Failure Functional
Status Inventory. A questionnaire assessed symptoms asking about their occurrence,
severity, and distress. The Psychosocial Adjustment to Illness Scale was used to measure
psychosocial adjustment to illness. Cantril’s Ladder was used to measure overall well
being o f the patients Assessment and reassessment occurred at enrollment, and at 1,3,
and 9 months after discharge from the hospital. The experimental group received
systematic education and support by a nurse in the hospital and at home. The control
group received routine care.
Jaarsma et al. (2000) results showed a significant decrease in the average number
o f symptoms at the 3-month timeframe for both groups (p< .001), from 3 .9 at baseline to
an average o f 1.9 symptoms in the control group and 2.2 symptoms in the intervention
group. Both groups also showed a significant decrease in average symptom severity after
discharge (p< .001) and a decrease in average symptom distress (p< .001).
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The five studies involving non-pharmacologie treatments did have some
limitations. Limitations o f Rich et al. (1995) and Kostis et al. (1994) are the inability to
generalize results and the brief duration o f both studies. A limitation o f Fonarow et al.
(1997) is also the inability to generalize results and that the data collection was done in
retrospect before referral. Another limitation o f both Rich et al. and Fonarow et al. is the
inability to distinguish or attribute the quality o f life changes to the study variables.
Small sample size was a limitation in both Kostis et al. and Oka et al. (2000). Jaarsma et
al. (2000) stated that a limitation o f the study was that the quality o f life instrument might
not have been sensitive to change over time.
Summary
Heart failure is a debilitating and costly disease, and its incidence continues to
rise. Much research has been done related to heart failure and how to manage the
disease. Much research has been done on heart failure and quality o f life, but a majority
o f this research has been descriptive and exploratory. Numerous studies define the heart
failure patient’s quality o f life as poor. Research studies reflect that the patient’s
symptoms and functional status are two reasons for a poor quality o f life, therefore the
focus o f many studies has been on decreasing symptoms or increasing functional status.
The few studies that have shown an improvement in quality o f life have involved
treatment that included an exercise program and an educational nursing component.
Future studies need to focus on how to improve quality o f life in the patient with heart
failure.. One way to do this may be through nursing education programs provided to
patients with heart failure that have shown to be effective in increasing the quality o f life
o f heart failure patients.
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Another issue surrounding quality o f life research and the heart failure patient is
the need to define quality o f life. Currently, quality o f life is defined differently from
study to study. There are many different domains o f quality o f life. The frequently used
domains include physiological, psychological, or psychosocial. Current studies have
researched one domain or all domains, utilizing a multitude o f instruments. Some o f
these instruments are disease specific while some are not. Future studies need to focus on
defining quality o f life in a similar fashion from study to study. M ore studies need to be
done utilizing an instrument that measures quality o f life and is specific to heart failure.
Research Question
Does a tertiary nursing intervention, supportive education, increase quality o f life
in patients with heart failure?
Study Hypothesis
Quality o f life scores for patients with heart failure that receive a supportive
educational nursing intervention will be higher than those patients receiving placebo
nursing interventions.
Definitions o f Terms
Heart failure: “A clinical syndrome or condition characterized by ( 1) signs and
symptoms o f intravascular and interstitial volume overload, including shortness o f breath,
rales, and edema or (2) manifestations o f inadequate tissue perfusion, such as fatigue or
poor exercise tolerance” (AHCPR Quick Reference Guide for Clinicians, No. 11, p. 1).
Oualitv o f Life: “A person’s sense o f well-being that stems from satisfaction or
dissatisfaction with the areas o f life that are important to him/her” (Ferrans & Powers,
1992, p. 29).
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Placebo nursing interventions: Nursing interventions for health promotion that include
topics such as immunizations for adults, decreasing risks for falls, general nutrition,
normal aging, general health maintenance, and insomnia.
Supportive educational nursing intervention: Nursing interventions that not only include
the placebo nursing interventions, but also nursing actions that guide, support and teach
the client in providing self-management for the health-deviation o f heart failure.
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CHAPTER 3
METHODOLOGY

Design
This study is a secondary analysis o f a primary study conducted by Kay
Setter- Kline, RN, PhD, Professor at Grand Valley State University in Allendale,
Michigan. The primary study utilized a blind, experimental design, comparing three
different nursing approaches with home care patients having a primary diagnosis o f
congestive heart failure. The three nursing approaches were supportive-education,
mutual goal setting, and a placebo intervention. The subjects were randomly assigned to
receive one o f these three nursing approaches. All subjects received nursing care
routinely provided by the home care agencies.
The long-term goal o f the primary study was to develop a program o f research
that would explain the relationship between nursing care and cardiovascular disease
outcomes, particularly heart failure. The outcomes the study were (a) increasing self
management o f heart failure as measured by the Self-Management Tool, (b) increasing
the quality o f life for persons with heart failure as measured by the Ferrans and Powers
Quality o f Life Index, (c) reducing hospital readmission rates, and
(d) decreasing length o f stay if admitted to the hospital.
According to Polit and Hungler (1995), the controlled experiment is considered
the “ideal o f science” and a double blind experiment, such as the primary study, has
greater power because it can control for experimental disadvantages. The advantage o f a
true experiment is that a causal relationship between the independent and dependent
variable may be inferred with confidence. One disadvantage o f a true experiment is that
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experiments seem artificial because o f the requirement for randomization and equal
treatment within groups. Another disadvantage o f a true experiment is the Hawthorne
effect, a placebo effect due to the subject behaving differently because o f participation in
the study.
The data for this secondary analysis used two o f the groups that were randomly
assigned from the primary study; the placebo group that received placebo nursing
interventions and the experimental group that received the supportive educational nursing
intervention. The quality o f life o f the two groups were compared in this secondary
analysis. There are advantages and disadvantages with secondary analysis. The
advantage o f secondary analysis is that it is efficient and economical Data collection can
be very expensive and time-consuming and secondary analysis bypasses this part o f the
research process. The disadvantage o f secondary analysis is that the investigator does not
play a role in the data collection, therefore the data set may not be exactly as the
researcher would have collected it (Polit & Hungler, 1995).
Sample
Subjects were selected for the primary study from two non-profit western
Michigan home care agencies from two different cities. A convenience sample was
utilized that met the following criteria; (a) a primary diagnosis o f heart failure, (b) over
the age o f 18, (c) able to understand and speak English, and (d) agreement to participate
in the study. The goal o f the primary study was to enroll 62 subjects for each o f the three
nursing intervention groups, for a total o f 186. This number o f subjects would achieve an
estimated power o f 80%. The primary study also tried to equalize the groups according
to the two sites, which would place 31 subjects in each group, at each site. Fifty-eight

42

subjects were included in this secondary analysis with 31 subjects in the placebo group
and 27 subjects in the supportive educational group.
Characteristics o f Sample Subjects
The demographic d ata included in this secondary analysis follows; (a) age;
(b) gender; (c) marital status broken down into 2 categories, never married or married,
which included divorce and widow/widower; (d) employment status, employed or
unemployed, (e) highest level o f education, (f) insurance provider, (g) health care
provider treating the heart failure, (h) annual income in dollars, and (i) length o f
diagnosis o f heart failure. The mean age of the subjects in the placebo group was 76
(SD =9.97) with a range o f 56 to 94 years The mean age o f the subjects o f the
supportive educational group was 75 (SD = 13.54) with a range o f 42 to 94 years. Both
the supportive educational and placebo group had a higher percentage o f females than
males within the sample, w ith 51.9% o f the supportive educational and 61.3% o f the
placebo group being female (see Table 2).
One subject from the supportive educational group and one subject from the
placebo group had never been married. The rest o f the subjects in both groups are
currently married, divorced, o r widowed. Almost half o f the subjects from the supportive
educational group (n=13) and half from the placebo group (n=15) were still married. The
other 48% o f the subjects from the educational group w ere either divorced (n=2) or
widowed (n=13). Forty-eight percent o f the placebo group were widowed (n=13) and
none were divorced. Only one subject from the placebo group was employed and worked
approximately two hours per week.
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Table 2
Characteristics o f Sub jects

Placebo Group

Supportive Educational Group

(n=31)

(n=27)

n

%

n

%

Male

12

38.7

13

48.1

Female

19

61.3

14

51.9

Married

15

48.4

13

48.1

Unmarried

16

51.6

14

51.8

1-7 years

3

9.7

1

3.7

8-10 years

5

16.1

4

14.8

11-12 years

19

61.3

13

48.1

> 12 years

4

12.9

9

33.3

< 10,000

9

29.0

5

19.2

10-20,000

9

29.0

12

46.2

20-30,000

11

35.5

8

30.8

30-40,000

2

6.5

1

3.8

Gender

Marital status

Highest level of education

Annual income in dollars
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Table 2 also shows the highest level o f education o f the subjects in both the
placebo and supportive educational intervention groups. Sixty-one percent o f the
subjects in the placebo group attended thel I*** or 12* grade, with 13% having some type
o f college education. The percent o f subjects in the supportive educational group that
attended at least the 11* or 12* grade is 48%, with 33% having some type o f post
secondary education. The main insurance provider for the subjects in both the placebo
and the supportive educational groups was Medicare. Ninety percent o f placebo group
(n=28) and 85% o f the supportive educational group (n=23) had Medicare.
Sixty-seven percent o f the subjects in the placebo group and 85 .2 % in the
supportive educational group had a cardiologist caring for their heart failure. The other
subjects had various other health care providers for their heart failure (see Table 3). The
length o f time since diagnosis o f heart failure was similar between the two groups.
Thirty-two percent of the subjects in the placebo group had heart failure for < 1 year
(n=10) and thirty-two percent had heart failure for > 5 years (n=10). The majority o f the
subjects in the supportive educational group had heart failure for > 5 years (n = 8), which
was 29.6% (see Table 4).
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Table 3
Health Care Providers

Supportive Educational Group

Placebo G roup
%

n

%

Family practice physician

08

25.8

3

11.1

Cardiologist

21

67.7

23

85,2

Internist

10

32.3

8

29.6

Nurse practitioner

3

9.7

1

3.7

Physician assistant

0

0.0

0

0.0

Other

3

9.7

3

11.1

Table 4
Length oFTime Diagnosed With Heart Failure

Placebo G roup

Supportive Educational Group

n

%

n

%

< 1 year

10

32.3

7

25.9

1-2 years

5

16.1

5

18.5

3-5 years

6

19.4

7

25.9

> 5 years

10

32.3

8

29.6
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Instruments
The primary study utilized two instruments, the Self-Management Tool adapted
from the Chronic Disease Self-Management Study Measures by Lorig et al. (1996) and
the Ferrans and Powers Quality o f Life Index: Cardiac Version-Ill (QLI) (Ferrans &
Powers, 1985, 1992). For the purpose o f this secondary analysis focusing on the quality
o f life o f the patient with heart failure, the QLI is the instrument that was used.

The QLI

is a 72-item scale consisting o f two parts. Part one measures “how satisfied” the subject
is with various aspects o f their lives. Responses range on 6-point Likert scale from ( 1)
very dissatisfied to (6) very satisfied. Part two measures the “importance” o f various
aspects o f their life, with responses ranging from ( 1) very unimportant to (6) very
important. Internal consistency with cardiac subjects has been reported from .86 to .96
(Biley & Ferrans, 1993). Content validity is supported by Ferrans and Powers (1985) and
by the study done by Oleson (1990). Contrasted groups (Ferrans & Ferrell, 1990; Ferrans
& Powers, 1992) also supported construct validity.
Reliability o f the Ferrans and Powers Quality o f Life Index: Cardiac Version-Ill
(QLI) was calculated for this secondary analysis. According to Polit and Hungler (1995),
a reliability coefficient o f .70 or greater is considered sufficient to make group
comparisons. The Cronbach alpha for all 72 items o f the QLI and the overall sample
(n=55) was .88. The reliability o f each subscale o f the QLI was also calculated (see
Table 5). The four subscales o f the QLI are health and functioning, social and economic,
psychological/spiritual, and family. Two o f the QLI subscales’ Cronbach alphas fell
below .70, social and economic and family. The small sample size, the number o f items
in the subscale, and the instrument itself may be reasons for the lower coefficients.
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Table 5
Reliability Coefficients o f the QLI Subscales

QLI Subscales

# of Items

Reliability Coefficient

Health & functioning

32

.85

Social & economic

18

.67

Psychological/spiritual

14

.82

8

.65

Family

Procedure
Approval for the primary study was obtained through the Grand Valley State
University’s Human Research Review Committee in order to protect the patients’ rights.
Recruitment o f subjects for the primary study consisted o f selecting cases from a list o f
clients admitted to the two home care agencies with a primary diagnosis o f congestive
heart failure (lCD-9 code o f 428). Patients that met the inclusion criteria were then
approached by the home care agency manager and introduced to the study utilizing a
script (see Appendix B). If the patient was interested in participating in the study, the
data collector, a graduate nursing student, made arrangements to visit the patient, explain
the study, obtain informed consent (see Appendix C), and collect the baseline data
utilizing a demographic data tool (see Appendix D). Once the data collector obtained the
baseline data. Dr. Setter-Kline, the primary investigator, randomly assigned the patients
to one o f the three treatment groups utilizing a table o f random numbers.
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A nursing intervention provider visited each patient once a week for a total o f
eight weeks. Each treatment group had a separate nursing provider. During the visits,
the nursing provider administered one o f the treatments. All groups received routine
home care interventions that consisted o f health maintenance topics. Data collection
occurred initially, and again at 3, 6, 9, and 12 months using the data collection
instruments. The initial data and the data obtained at the 6-month time frame was the
data utilized for this secondary analysis.
The data were coded using a numerical coding system in order to identify the
patients and to protect their confidentiality. There were no physical risks to the patient
during the data collection or intervention sessions, except possible fatigue. The nursing
provider assessed this on an individual basis during the sessions. If signs o f fatigue
occurred, the session was terminated.
Approval to conduct this secondary analysis was obtained from Grand Valley
State University’s Human Research Review Committee (see Appendix E). Permission
was obtained to use the data for this secondary study from Dr. Setter-Kline, the principal
investigator of the primary study (see Appendix F).
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CHAPTER 4
RESULTS

The purpose o f this study was to determine if a tertiary nursing intervention,
supportive education, had an effect on the quality o f life o f patients with heart failure.
The research question for this study was, “Does a tertiary nursing intervention, supportive
education, increase quality o f life in patients with heart failure?” The hypothesis in this
study was as follows; Quality o f life scores for patients with heart failure that receive a
supportive educational nursing intervention will be higher than those patients receiving
routine nursing interventions.
Data were analyzed using the Statistical Package for the Social Sciences (SPSS).
In order to test the hypothesis for this study, analysis o f covariance (ANCOVA) was
considered. The ANCOVA would control for pre-test differences between the two study
groups. Due to the small sample size o f this secondary analysis the use o f the ANCOVA
was prohibited. Instead, independent and paired t-tests were performed. The
independent t-test compared differences between groups and the paired t-test compared
changes within a group. The level o f significance was established at p< .05.
Overall Quality o f Life Scores
The QLI scores are determined by weighting satisfaction with the importance o f
each identified item o f the QLI scale. These scores range from 0 to 30, with 0 being the
lowest QOL score and 30 being the highest. The QLI scores o f heart failure patients
were measured at baseline and at the 6-month time frames in the two groups being
studied, the placebo and supportive educational groups.

50

The baseline QOL scores for the placebo group (n = 3 1) ranged from 10.07 to
28.25, with a mean o f 20.71 (SD = 5.04). Eighty-four percent o f subjects in the placebo
group had scores greater than 15, which was the midpoint in the scale. At the 6-month
time frame, the QOL scores (n = 24) ranged from 9.30 to 27.47, with a mean o f 20.77
(SD = 4.97). Ninety-two percent o f the subjects in the 6-month time frame had QOL
scores greater than 15.
At baseline, the QOL scores for the supportive educational group (n = 27) ranged
from 13.04 to 26.99, with a mean o f 20.87 (SD = 3.75). Ninety-three percent had scores
greater than 15. The range o f the QOL scores for this group (n = 17) at the 6-month time
frame is 13 .51 to 28.82, with a mean o f 23 41(SD = 4.47) and 89% o f the subjects had a
score greater than 15. Table 6 summarizes these results.
Hypotheses
“Quality o f life scores for patients with heart failure that receive a supportive
educational nursing intervention will be higher than those patients receiving a placebo
nursing intervention” was the hypotheses that was tested. The data analysis indicated a
slight improvement in the mean QOL scores over time for both groups, with the
supportive educational group having a greater increase. The expectation would be that an
increase in QOL scores would be an increase in QOL. There was a 16 increase o f the
mean QOL scores for the placebo group from baseline to 6 months, and a 2.64 increase
for the supportive educational group. In order to determine the statistical significance o f
this increase and test the hypothesis, an independent t-test w as done which tests for the
statistical significance o f differences between two group means.
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Table 6
Quality o f Life Scores

n

Range

Mean

SD

Baseline time frame

31

10.07-28.25

20.72

5.04

6-month time frame

24

9.30-27.47

20.77

4.97

Baseline time frame

27

13.04-26.99

20.87

3.75

6-month time frame

17

13.51-28.82

23.41

4.47

Placebo

Supportive Educational

As shown in Table 7, the difference in the mean QOL scores between the two
groups was not significant. Therefore the research hypotheses was not supported.
Table 7
Difference Between QOL Scores At Baseline and Six Months

Timeframe

t

df

P

Baseline

-0.13

55

.897

6-month

-1.74

39

.089

A paired sample t-test was done on both the placebo and the supportive
educational group in order to determine if the changes in the QOL mean scores within
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each group were significant. The overall QOL scores and QOL subscale scores were
both analyzed. The QOL subscales are health and functioning, social and economic,
psychological/spiritual, and family.
The paired sample t-test did not show any significant difference in the change in
the overall QOL scores for the placebo group (n=24), however it did show a significant
decrease in the social and economic subscale score (t = 2.77; d f = 23; p = .011) in this
group. The supportive educational group (n= 17) had a significant increase in the overall
QOL scores (t = -2.90; d f = 16; p = 0.01), along with the health and functioning subscale
scores (t = -3.27; d f = 16; p = .005). Table 8 shows the significant results from the paired
t-test analysis.
Table 8
Paired t-test Analvsis

Mean Baseline
Score (SD)

Mean 6-Month
Score (SD)

22.63 (5.11)

20.92 (5.55)

Supportive Educational
Overall QOL 21.52(3.68)
18.72 (5.18)

QOL
Subscale

Placebo
S& E

H&F

t

df

P

2.77

23

O il

23.41 (4.47)

-2.90

16

.01

21.52 (6.40)

-3.27

16

.005

Note: S&E = social and economic subscale; H&F = health and functioning subscale
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CHAPTER 5
DISCUSSION AND IMPLICATIONS

Discussion
The purpose o f this secondary analysis was to examine the effect o f a supportive
educational nursing intervention on quality o f life (Q O L) in patients with heart failure.
The hypothesis, “Quality o f life scores for patients with heart failure that receive a
supportive educational nursing intervention will be higher than those patients receiving
placebo nursing interventions,” was not supported. W hile the supportive educational
group did increase QOL scores from baseline to the 6-month time frame, the change in
scores was not statistically significant.
According to Polit and Hungler (1995), it can be very difficult to figure out why a
hypothesis is not supported. One possible reason the hypothesis was not supported in this
secondary analysis may be due to the loss o f subjects o r attrition. There are many
reasons why subjects are unable to continue the study. The patients that left the study
could have had the poorer QOL, and would have had the most potential to increase their
QOL. If this was a correct assumption, then the patients that remained may have had a
good QOL and did not really have a need to increase their QOL.
The small sample size is another possible reason the hypothesis was not
supported. The sample size was small at the initial collection o f data and decreased
significantly at the 6-month time frame. Since it appears that the overall QOL score for
the supportive educational group had increased more than the placebo group scores, a
larger sample size may have been able to show statistical significance in regards to the
hypothesis.
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The time frames in which the data were collected could have had an effect on the
hypothesis. Data were available for 3 months, 9 months, and 12 months, along with the
6-month data. The 6-month time frame was chosen in order to give the subjects time
after the intervention occurred to adjust to the life style changes and incorporate the
education and support that they received. If the 3 month data had been used, the attrition
rate may not have been as high and the post-intervention sample may have been larger.
The ability to measure QOL may be a reason that the hypothesis was not
supported. The reliability and validity o f the Ferrans and Powers Quality o f Life Index.
Cardiac Version III (QLI III) has been widely validated over the recent years. However,
quality o f life is subjective and the QLI-lII measures QOL in objective terms. The QLIIII measures scores on a scale o f 0-30. It is unclear which score determines a poor QOL
or a good QOL? Someone may have a score near 30 and perceive that their QOL is very
poor, or someone may have a score o f 10 and perceive that their QOL is good.
Therefore, measures for subjective data are required.
Other reasons for the hypothesis not to be supported could be the potential bias o f
the nurse providers. Did the nurse providers carry out the interventions exactly the same
with each patient? The interactions that the nurse providers had with each patient could
produce bias, therefore skewing the results.
Fatigue was an area o f concern during the primary study when the data were
collected and fatigue could have been a factor in the results obtained. Since the visits
from the graduate student nurse provider was in addition to their routinely scheduled
home visit, the nurse provider needed to assess the patient for signs o f fatigue. Did the
nurse provider have experience in assessing for signs o f fatigue and was it actually
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assessed during the intervention? If the nurse provider did not do a good job at assessing
for fatigue during the data collection or treatment administration, this could have affected
the results. Hawthorne and Hixon (1994) who also utilized the QLI-III in measuring
QOL, found indications during their study that this instrument may have caused fatigue,
especially in the second portion o f the tool
There is limited research evaluating the effects o f nursing interventions on QOL
in the patient with heart failure In a meta-analysis that Kinney et al. (1996) completed
on this subject, one intervention study out o f 67 was a nursing intervention, with 48 o f the
other intervention studies being pharmacological Out o f 46 studies that Leidy, Rentz,
and Zyczynski (1999) reviewed evaluating QOL outcomes in patients with heart failure,
only two involved nursing interventions.
Jaarsma et al. (2000) demonstrated similar results in a study conducted with
patients with advanced heart failure that received a supportive educational nursing
intervention. Both o f the groups in the Jaarsma’s et al. study, the control group that
received routine nursing care and the experimental group that received supportive
education, did show improvement in the QOL dimensions after the baseline measurement
but with no differences between the two groups at subsequent follow-up times.
Two other nurse intervention studies demonstrated results that were more
conclusive than this secondary analysis. Rich et al.’s (1995) study demonstrated that a
nurse-directed, multidisciplinary treatment strategy could improve the heart failure
patient’s quality o f life. Both groups did improve their QOL over time, as in the Jaarsma
et al. (2000) study, but there was significantly more improvement in the group that
received the nurse-directed intervention.
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Hawthorne and Hixon (1994) examined the effects o f a nurse monitored,
symptom management program on hospital readmission rates and QOL in patients with
chronic heart failure. Quality o f life did not improve until the patients were stratified by
activity levels and the higher activity group had a statistically significant increase in QOL
scores.
The study done by Kostis et al. (1994) compared three treatments - placebo,
digoxin, and a multimodal nonpharmacologic intervention. Though this study was not
categorized as a nursing intervention study, the nonpharmacologic intervention consisting
o f exercise training, cognitive therapy and dietary intervention is similar to the nursing
interventions discussed in the literature. The Kostis et al. study evaluated if any o f the
three treatments improved functional and emotional status, two dimensions o f QOL, and
concluded that the nonpharmacologic intervention did improve functional status and
mood state.
Neuman’s systems model has assisted in guiding this research. According to
Neuman (2002), the major concern for nursing is to keep the client system stable through
accuracy in assessing the effects o f stressors. Nursing must also assist in client
adjustments that are required for an optimal wellness level, meaning the best possible
state achievable at a given point in time. Nursing actions are initiated to retain, attain,
and maintain optimal client health o r wellness. The three preventions as interventions,
primary, secondary, and tertiary prevention, assist in keeping the client stable. The type
o f intervention needed depends on the degree to which stressors have penetrated the
client's lines o f resistance. Tertiary interventions return the client to wellness, or
reconstitution, following treatment after some degree of stability has occurred.
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Quality o f life can be viewed on a continuum as the Neuman Systems Model
views health and wellness. The dimensions o f QOL are similar to the variables in the
Neuman model, acting in balance and harmony to maintain stability. The patient’s
perception o f quality o f life, or placement on the continuum, is dependent on the degree
o f stability and assessment o f which stressors are affecting this stability. For example, the
patient newly diagnosed with heart failure has stress in learning how to adjust to this
disease process, including symptoms, treatment, and life style changes. This stress
causes a reaction manifested by a decrease in QOL.

Nursing needs to assist in bringing

the patient to a perception o f optimal quality o f life through a tertiary intervention, such
as a supportive educational intervention. According to Neuman (2002), tertiary
interventions support internal and external resources in order to bring the patient back to
reconstitution.
The research question for this secondary analysis was “ Does a supportive
educational nursing intervention increase quality o f life in patients with heart failure?”
Even though the findings did not support the hypothesis, the findings did substantiate that
a supportive educational nursing intervention does increase QOL in patients with heart
failure. The overall QOL scores did increase in both the placebo and supportive
educational group, but the increase was only statistically significant in the supportive
educational group, not the placebo group. These findings along with the findings from
previous research (Hawthorne & Hixon, 1994; Jaarsma et al., 2000; Kostis et al., 1994;
Rich et al., 1995) suggest the importance o f education, support, and intense follow-up in
increasing QOL in patients with heart failure.
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The supportive educational group’s overall QOL scores and all four subscales o f
the QLI-lIl increased from baseline to 6-months. The increase in the overall QOL score
and the health and functioning subscale were statistically significant in this group The
placebo group’s overall QOL scores and two of the subscales, health and functioning and
psychological/spiritual, also increased but were not statistically significant The placebo
group did have a statistically significant decrease in the QOL subscale o f social and
economic.
In two longitudinal studies that measured QOL over time, these findings were
supported in one and not in the other. The SUPPORT study (Jaagoslid et al., 1998),
discovered that QOL improved over time without any intervention. The GLAS study
(VanJaarsveld et al., 2001 ) discovered that QOL decreased over time without any
intervention. The findings o f the SUPPORT study would make the researcher question if
the increased QOL were due to the supportive educational intervention or to the passage
o f time. On the other hand, the findings o f the GLAS study would suggest that the
supportive educational intervention was the reason for the increase in QOL.
Findings from Grady et al., (1995), Friedman and Griffin, (2001), and Mayou et
al., (1991) support the significant increases in the supportive educational group. All three
o f these studies correlated symptom distress and physical functioning with QOL.
Therefore, if an intervention provided the education and support to decrease symptoms
and increase physical functioning, QOL may be improved as it was in the supportive
educational group.
Another reason for the significant results could be related to attrition or bias. The
patients that dropped out o f the study could have been the sicker patients, or the patients
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with the poorer quality o f life. This would leave patients that may have been more able
to increase their QOL significantly.
Although not analyzed in this secondary analysis, gender makeup o f the placebo
group could have affected the overall QOL results and the significant decrease in the
social and economic subscale o f the placebo group. The supportive educational group
was composed o f 48% females, while the placebo group was composed o f 61% females.
According to three recent studies (Chin & Goldman, 1998; Cline et al, 1999; Reidinger et
al., 2001), it was found that women with heart failure had a lower QOL than men with
heart failure. Since the placebo group had a higher percentage o f women than the
supportive educational group, this may be why the increase in the overall QOL scores for
the placebo group was not statistically significant. Gender differences may also help to
explain the decrease in the social and economic subscale o f the placebo group. Riedinger
et al. also discovered that social scores were significantly worse in women than in men
Bennett, Baker, and Huster (1998) conducted a study on QOL and women with heart and
significantly correlated low social support with physical symptom impact.
Many research studies done on patients with heart failure classify the patients into
a severity rating, such as the NYHA functional classification (Cline et al., 1999; Dracup,
Walden, Stevenson, & Brecht, 1992; Fonarow et al., 1997; Grady, et al., 1995;
Hawthorne & Hixon, 1994; Jaarsm a et al., 2000; Kostis et al., 1994; Mayou et al., 1991;
Oka et al., 2000; Shah et al., 1998; Walden et al., 1994). In the studies done by Cline et
al., Grady et al., and Dracup et al., it was discovered that the higher the NYHA
classification, the poorer the QOL. Severity o f disease may be an explanation for poorer
QOL and could have assisted in explaining why the hypothesis was not supported. The
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makeup o f the two groups in regard to severity o f disease may have been unequal,
therefore affecting the results o f this secondary analysis.
Limitations
A limitation o f doing a longitudinal study is the loss o f subjects or attrition. Loss
o f subjects occurred between the baseline collection o f data and the 6-month time frame
in both the supportive educational and the placebo group. The placebo group lost seven
subjects, which was approximately 23% o f the subjects included in the sample when the
initial data were collected. The supportive educational group lost 10 subjects, which is
more than one third o f the initial subjects. According to Polit and Hungler (1995),
attrition can introduce bias by changing the composition o f the initial sample, particularly
if more are lost from one group than the other and attrition rates exceed 20%.
Because of attrition, the sample size became smaller at the 6-month time frame.
The supportive educational group had 17 and the placebo group had 24 subjects at the 6month time frame. According to Polit and Hungler (1995), the larger the sample, the
more representative o f the population it is likely to be. Small sample sizes also run the
risks o f a large standard error. A large standard error could result in the rejection of a
hypothesis, even when the hypothesis may be correct.
Another limitation that could not be controlled is maturation. Physical growth,
emotional maturity, and fatigue are examples o f maturation (Polit & Hungler, 1995).
Worsening or improvement o f symptoms can occur due to the subject or the disease
process. This can affect quality o f life either in a positive or negative manner. The
increase in QOL scores for the supportive educational group may be due to this
maturation process and not due to the intervention.
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Testing effect is another limitation o f this study. Sensitization could have
occurred after the questionnaire was completed initially. In the primary study, the
subjects were tested at baseline, 3 ,6 ,9 , and 12 months. This secondary analysis only
utilized two timeframes, the baseline and 6 months. At the 6-month time frame, the
subjects had already completed the QLI-III twice.
There are limitations associated with secondary analysis. The main limitation is
that the researcher is limited to studying the available data and variables contained in the
primary study. The researcher may find that other data may be helpful to answer the
research question or support a hypothesis.
Implications for Nursing
As heart failure mortality improves through advances in medical and surgical
management, people will live longer with a very disabling disease process. Reducing
mortality and improving QOL are observable outcomes that the AHCPR has determined
to be o f primary importance when discussing treatment effectiveness (Hadom et al.,
1994). Outcomes such as decreasing mortality and increasing QOL do not necessarily go
together. Decreasing mortality does not necessarily increase QOL. Decreasing heart
failure mortality may mean having to live with a complex disease that requires dramatic
lifestyle changes.

Increasing or maintaining QOL may mean learning how to deal with a

complex disease and the lifestyle changes that accompany it.
Nurses have a great opportunity to affect patient outcomes and validate the
science and art o f nursing. Nursing is the discipline highly qualified to assess, educate,
support, and care for patients with heart failure and assist in bringing them to the highest
level o f quality o f life possible. Nurses need to continue to treat patients in a wholistic
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manner, caring for all aspects of the patient with heart failure, including the
physiological, psychological, social, economic, developmental and spiritual variables.
Although the hypothesis o f this secondary analysis was not supported, there was
evidence that a supportive educational nursing intervention did increase quality o f life in
patients with heart failure. Since it was difficult to compare this study with other studies
due to variations in measurement instruments and data collection time frames, further
studies need to utilize the same data collection time frames and QOL measurement tools.
Nurse scientists need to continue to study the issues that surround the patient with heart
failure and quality o f life. It is important to continue to research the effects o f nursing
interventions on quality o f life, especially in chronic diseases such as heart failure,
cancer, diabetes, and chronic obstructive pulmonary disease. Nurse scientists also need
to mentor and motivate others to participate in the research process.
Nurse educators can assist in improving heart failure patient outcomes by insuring
nursing school curricula address quality o f life issues from the patient, family, and care
giver perspectives. Students need to be prepared to assist and care for patients with
chronic diseases, such as heart failure. Quality o f life issues will increase as technology
increases and is a very important part o f caring for a patient with a chronic illness.
Nursing curricula need to stress the importance o f nursing research, assist in
understanding the research process, and demonstrate to students how to incorporate
research into their practice.
Nurse administrators can also play a role in improving outcomes in the heart
failure patient. They need to base nursing policies and procedures on evidence-based
practice and outcomes. In order to decrease the cost o f heart failure and improve QOL
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outcomes in patients, nurse administrators need to implement strategies that keep heart
failure patients out o f the hospital and out o f the emergency rooms. Strategies that
decrease symptoms and increase functional capabilities are some o f the same strategies
that increase QOL. They need to search for opportunities for research within their
administrative area and support staff research initiatives. Administrators need to be
willing to allow nurse scientists to conduct research studies in their practice settings.
Advance practice nurses can have an impact on improving quality o f life for
patients with heart failure. Advance practice nurses are familiar with research and utilize
evidence-based nursing approaches in their practice. With shorter lengths o f stays in the
hospitals, patients need to be well educated on how to care for themselves. The advanced
practice nurse that practices in the hospital setting is able to provide nursing interventions
that prepare the patients to be discharged home. The advanced practice nurse that
practices in the tertiary care setting, such as a clinic o r office, can continue to provide
nursing interventions in order to maximize the patient’s functioning and QOL.
Recommendations
Heart failure is a debilitating and costly disease, which is increasing in incidence and
prevalence. Heart failure not only affects patients, it affects families, and society.
Research conducted on the heart failure population and QOL has shown that patients with
heart failure have a poor quality o f life (Cline et al., 1999; Dracup et al., 1992; Muirhead
et al., 1992; Reidinger et al., 2001; VanJaarseld et al., 2001; Walden et al, 1994). Recent
research studies have focused on medical or surgical strategies to decrease heart failure
mortality and morbidity, and increase QOL. Investigations need to continue in order to
identify variables that affect quality of life, either positively or negatively.
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It would be interesting to continue the primary study or replicate it, in order to
obtain a larger sample and to exam ine if the hypothesis for this secondary analysis would
be supported. Future research is needed on nursing interventions that improve quality o f
life in the heart failure patient, and decrease hospital readmission and decrease physician
or emergency room visits. Specifically, interventions that take place in the home or
within nurse based clinics would be very beneficial because more care is being done on
an outpatient basis. More research also needs to be done on evaluating the costeffectiveness o f nurse-directed care at home or in clinic settings.
Quality o f life needs to be defined. Each study seems to have a slightly different
variation o f the definition. Some definitions discuss one dimension o f QOL and some
discuss multiple dimensions. The same issue arises with QOL instruments. Some
instruments measure just one dimension o f QOL and others measure multiple
dimensions. This makes it difficult to compare and contrast study results. Consistent
instruments that measure QOL the same way need to be used in future studies. These
instruments need to be valid and reliable.
Quality o f life needs to be examined from the patients’ perspective. Quality o f
life is very subjective and the research continues to try and measure it with objective
tools. In order to fully understand quality o f life, we need to listen to what the patient is
telling us. Examination o f the patients’ perception o f QOL needs to be attained through
avenues such as interviews. The common themes o f these interviews can then assist in
development o f quantitative or qualitative studies that truly affect QOL outcomes from
the patients’ perspective.
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Summary
Heart failure and its treatment are very complex, with numerous physical and
psychological components. Successful management o f heart failure requires lifestyle
modifications, education, and counseling. Many studies have demonstrated that
symptom distress, physical and psychological, is one large reason for a poor QOL
(Dracup et al., 1992; Friedman and Griffin, 2001; Grady et al., 1995; Mayou et al., 1991;
Muirhead et al., 1992; Walden et al., 1994). An assumption can be made that by gaining
a better understanding o f heart failure and its treatment, patients will be better able to care
for themselves, which in turn decreases symptom distress. If symptom distress decreases,
QOL may increase.

Any nursing intervention that provides the necessary education and

support to decrease severity o f symptoms and level o f distress could then increase QOL.
The purpose o f this secondary analysis was to determine if a supportive
educational nursing intervention increased quality life in patients with heart failure. Even
though the hypothesis was not supported, there tended to be an increased QOL for
patients who received the supportive educational approach at the 6-month time period.
These findings seem to validate the importance o f a comprehensive educational and
supportive program for patients with heart failure and nursing is the discipline that has
the knowledge and expertise to deliver such a program. There is much research
supporting the hypothesis that QOL is poor in the patient with heart failure. Missing is
the effect that nursing interventions can have on increasing QOL. This study is one
attempt to explain the effect that nursing approaches may have on QOL. Quality o f life is
a very important clinical outcome and nursing research needs to be conducted to
determine ways to improve it.
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Michelle JohnaM
Pemiaskms A<kninitfraior
Legal Division 2C37

January 11,2002
Julie Switek
125 E lm S t
Hopkins, MI 49320
Dear Ms. Switek:
You have our permission to use figure 1-3 Iran our text, THE NEUM AN SYSTE M S
MODEL 4/e by NeiammH^eweett, in your M aster's o f Science thesis for (jn n d Valley
State University.
Your thesis is on the effects o f a supportive educative nursing intervention on the heart
fidlure patient’s quality o f live.
You may credit our material as follows-

Neumam/Faweem THE NEUMAN SYSTEMS MODEL, 4Æ, 02ÙÙL Reprinted by
permissinm of Pearson Edmeatiom, Inc,, Upper Saddle River, New Jersey.
Sincerely,

f

Michelle Johnson
Permissions Administrator
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Hopkios, Mi.
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Phone: 616-341-8976
Emeü address, jswitck@asca.org
Fax: 616-3414249

January 14,2002
Betty Neuman, PhD, RN, FAAN
PO Box77
Watertown, Ohio 45715

Dear Dr Neuman,
l a ma Master of Ssknoe in Nursing student at Grand Valley State University As a requirement
for graduation, I am doing a thesis on the efféct o f a supportive educative nursing imaveniioo on
the quality of üfc o f heart Adure patients I am using t ^ Neuman Systems Model for the
theoretical framework. 1 would like permission to reproduce the diagram of your model from the
book The Neuman Systems Model, 4th edition, by Betty Neuman and JaoqueiiiK Fawcett The
diagram in question is Figure 1-3. on page 13. I have already received pentnsston from Pcunon
Education, Inc.
If you have any questions or concents, fdcasc fed free to contact me.

Stdoerely,

JuUe Switek
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Script to Obtain Consent
My name i s ___________ . I am a registered nurse. I am taking classes at Grand Valley
State University to obtain a M asters Degree in Nursing. I have been given permission by
your home health care agency to come here today with your home health care nurse to
determine if you are willing to let me explain a nursing research study that is being
conducted with people like yourself who have been diagnosed with congestive heart
failure and are receiving home care.
After your nurse has finished providing your care today may I stay a few minutes to
explain the nursing research study we are doing? (If verbal permission is granted,
proceed with explanation o f study and obtaining informed consent after the home care
nurse has left).
Explanation o f Study
As nurses we are concerned with how people adjust to the medical diagnosis o f heart
failure. We want to find nursing approaches that will help you learn how to self-manage
your heart failure. We believe that when you can self-manage your heart failure you will
live a better life.
The study will consist o f five (5) interviews of approximately 45 minutes duration for the
purpose o f obtaining information about your health failure. You will be given $10 at the
completion o f each o f these five interviews as compensation for your time. The
interviews will be spaced three months apart, starting this week. If you agree to
participate you will be placed in one o f three groups.
Each group will receive a different approach to managing health. Each o f the nursing
approaches will be provided in addition to the regular care you receive from your home
care nurse at no extra cost. Another graduate nursing student who will call you to make
an appointment to come to your home will provide each nursing approach to you in
weekly 30-minute visits. If you participate in the study, I will give you the names o f the
students who call you. There will be a total o f eight weekly visits. Each visit will
provide you with information about managing your health. All visits will be scheduled at
your convenience, similar to your current home care visits. You will not be given
compensation for these eight visits.
Your participation in this study will in no way affect the regular care you receive from
the home care agency, and it may help you improve your self-management of heart
failure symptoms. The results o f this nursing study may help nurses determine better
ways to help other people with heart failure to improve their lives.
Because this is a nursing research study, I will maintain the confidentiality of the
information obtained during the interview. Your name will not be identified with any o f
the information I collect. When reporting the results o f the study only groups results will
be shared; no names o f individuals will be published. The nurses providing you home
care will not be told that you are participating in the study.
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APPENDIX C

Informed Consent
•

I ____________________ agree to participate in the nursing research study for persons
with heart failure who are receiving home care. I understand that as a participant in
this study; I will be interviewed for five (5) times for approximately 45minutes each
time, once within this week and again at 3, 6, 9, and 12 months. I will be
compensated $10 at the completion o f each interview.
• I will receive information about managing my heart and that this information will be
delivered by a registered nurse who is a graduate student at Grand Valley State
University.
• I will receive this information once a week over the next eight weeks and that each
visit will last approximately 30 minutes. I will not be compensated for receiving this
information.
• I will be able to withdraw from the study at any time by notifying Dr. Kay SetterKline, the principle investigator at 616-895-3517, and that my withdraw will in no
way affect the care I receive from the home care nurse.
• I will not be identified by name with any o f the information obtained and that sharing
o f Information obtained in this study will be in the form o f group summaries o f all
participants.
• There is no identified risk from participating in this study and I may benefit from
receiving information about ways to mange by health.
• If in the process o f gathering information any symptoms are identified that might
need attention the nurse gathering the information will refer me to either the home
health care agency or my health care provider.
• I also give permission for review o f my health records to verify my health care status.
If I have any questions about the research I may contact the Primary Investigator, Dr.
Kay Setter Kline at 616-895-3517 or the Chair o f Research Review Committee, Paul
Huizenga at 616-895-2472 at Grand Valley State University.

Signed

Date

Witness

Date

The names o f the students who are participating in this study are:
and
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APPENDIX D

DEMOGRAPHIC DATA
(To be collected at time o f initial interview)
A ge______________
2.

Marital Status
Never Married
Married
Divorced
Widow/Widower

3.

Employment Status
Employed (
Unemployed

4.

hours per week)

Highest Level o f Education
1“* - 7*** grade
8*^- 10‘*'grade
11* - 12* grade
Associate’s Degree
Bachelor’s Degree
M aster’s Degree
Doctoral Degree
Insurance Provider
Private Insurance (Name o f C om pany)_____
HMO (Name o f Group)___________________
Medicare
Medicaid
Supplemental Insurance (Name o f Company)
PPO (Preferred Provider O rganization)_____
Other

6.

Health Care Provider
Family Practice Physician
Cardiologist
Internist
Nurse Practitioner
Physician Assistant
Other
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Record Num ber.
Subject Number;

7.

Annual Income in Dollars:
less than $ 10,000
$ 10,001 - $ 20,000
$20,001 - $30,000
$30,001 - $40,000
$40,001 - $50,000
over $50,000

8.

How long have you had heart failure?
less than 1 year
1 - 2 years
3 - 5 years
more than 5 years.

9.

List current medical diagnoses._______
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G r a n d Xâ l l e y
St a t e U n i v e r s i t y
I CAMPUS DRIVE • ALLENDALE MICHIGAN 49401-9403 • 616/895-6611

November 21,2002

Julie Switek
125 Elm St.
Hopkins, MI 49328

RE; Proposal #03-112-H
Dear Julie:
Your proposed project entitled Providing a Tertiary Nursing
Intervention: Does It Affect the Quality of Life in Patients With Heart
Failure has been reviewed. It is exempt from the regulations by section
46.101 of the Federal Register 46( 161:8336. Januarv 26. 1981.

Sincerely,

f^cuJL HPaul Huizenga, Chair
Human Research Review Committee
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APPENDIX F

Cæ a n d A à l l e y

St a t e O

sh verstty

I CAMPUS DRIVE • ALLENDALEMICHIGAN 49401-9403 • 616/895-6611

January 12, 1999

Kay Setter Kline
222 HRY
Kirkhof School of Nursing
Dear Kay:
The Human Research Review Committee of Grand Valley State University is charged
to examine proposals with respect to protection of human subjects. The Committee has
considered your proposal, "Home Care Outcomesfor Heart Failure: A Test of Two
Nursing Interventions", and is satisfied that you have complied with the intent of the
regulations published in the Federal Register 46 (16): 8386-8392, January 26, 1981.
Sincerely,

Paul Huizenga, Chair
^
Human Research Review Committee
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